Skip to main content

Hematology-Oncology Fellowship

The Division of Hematology/Oncology at Indiana University School of Medicine is a part of the IU Melvin and Bren Simon Comprehensive Cancer Center, a National Cancer Institute (NCI)-designated comprehensive cancer center, and the only center with such distinction in Indiana. The school’s Division of Hematology-Oncology is comprised of a diverse faculty with expertise in every major hematologic and oncology disease. The division has a multi-disciplinary clinic in prostate cancer, lung cancer, breast cancer, gastrointestinal tumors, head and neck cancer, melanoma, testicular, bone marrow transplant, and precision genomics, among others.

Indiana University's Hematology/Oncology Fellowship is one of the oldest programs in the United States, being established by Dr. Lawrence Einhorn in 1975. Graduates from IU have a long track of success including two ASCO presidents, one ASH president, four ASCO presidential candidates, and ten faculty that have served as chairs on various ECOG committees. Indiana University has published multiple landmark trials in the areas of lung, colon, bladder, breast, pancreas, ovarian, germ cell tumors, anti-emetics, quality of life, and survivorship. Indiana University is credited with making the previously fatal disseminated testicular cancer the now highly curable disease we see today. Research from IU has also led to FDA approval of six drugs. 

Advanced Hematology-Oncology Training

For specific questions, including details on how to apply, interested physicians can contact the Fellowship Coordinator.

Program Leadership

Video

Hematology-Oncology Fellowship

Learn more about the Hematology-Oncology Fellowship program from current and past fellows.

National and International Leadership

In addition to their clinical expertise, IU School of Medicine faculty have been a part of serving as national and international leaders. Excellent mentoring opportunities over the years have assisted many IU School of Medicine Hematology/Oncology Fellowship graduates in becoming national and international leaders in their respective fields.

  • American Society of Clinical Oncology ASCO
    Lawrence Einhorn, MD, in 2000-2001 and Dr. George Sledge in 2010-2011 served as prior presidents of American Society of Clinical Oncology (ASCO). Several IU School of Medicine faculty and former fellows serve in other leadership capacities for ASCO, including the Board of Directors.
  • American Society of Hematology ASH
    Hal Broxmeyer, PhD, served as president of the American Society of Hematology (ASH) in 2010.
  • Oncology Drug Advisory Committee ODAC to the FDA
    Several IU School of Medicine faculty and former fellows serve in leadership capacities as members of the Oncology Drug Advisory Committee (ODAC) to the FDA.
  • Oncology Journals
    Several IU School of Medicine faculty and former fellows serve as editors of major oncology journals, including the Journal of Clinical Oncology (JCO).

Clinical Training

Each fellow has a continuity-of-care clinic throughout their three-year fellowship, where the fellow is autonomous to care for a cohort of patients under the direction of committed faculty. This includes a hematology or oncology clinic at the VA Medical Center or Eskenazi Health. In addition, each fellow has a rotating three-month sub-specialty clinics throughout their three years. Fellows have the unique opportunity to rotate at Indiana Hemophilia and Thrombosis center, focusing on benign hematologic conditions. While on the in-patient or consult services at IU Health, Eskenazi or the VA, the fellow plays a prominent role as the junior attending, supervised by a faculty member.

Former fellows have spread across the country at academic institutions and throughout the community to practice their skills. 

Academic/Research Experience

Within the program, each fellow is expected to engage in a mentored research project during their fellowship. Unique opportunities exist for fellow research, including the Komen Tissue Bank, Brown Center for Immunology, Walther Cancer Institute, Regenstreif Institute, BIG 10, Research Consortium, and the Hoosier Cancer Research Network, which is a community-based oncology group that provides an excellent opportunity for fellow led clinical trial design. Support is available for additional training in Masters of Public Health, Masters of Clinical Research, and Clinical Pharmacology. 

Teaching and Mentorship

Formal conferences are considered to be a central part of the fellow’s education. These include weekly subspecialty multi-disciplinary conferences, educational lecture series, academic half-days, grand rounds, and monthly journal club. Mentorship is provided by both individualized faculty and a formal mentoring committee.

Conferences Education Series
Weekly Case Conference and Lecture Series Immersion week for first-year fellows, providing protected time to focus on learning core principles of hematology/oncology and concentrated orientation experience
Weekly Lymphoma/Leukemia Fellows conference Research Foundation Workshop, designed to educate fellows on the basic skills of protocol and grant writing. Fellows are encouraged to apply for funding via this educational series.
Weekly Cancer Center Grand Rounds
Monthly Oncology Journal Club
Monthly Academic “Half-Day,” a unique learning experience with a Meet the Professor component
Monthly Chief Rounds
Annual ASCO Review Course
Landmark Trials Series and Board Review Materials



For more information about the program or information on how to apply, contact the Fellowship Coordinator.